Tyler Atkinson, PA-C | |
13 Industrial Park Rd, Saco, ME 04072-1804 | |
(207) 283-8800 | |
Not Available |
Full Name | Tyler Atkinson |
---|---|
Gender | Male |
Speciality | Physician Assistant |
Location | 13 Industrial Park Rd, Saco, Maine |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1376273243 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | PENDING (Maine) | Secondary |
363A00000X | Physician Assistant | PA2395 (Maine) | Primary |
Mailing Address | Practice Location Address |
---|---|
Tyler Atkinson, PA-C 87 Sherwood St Apt 2, Portland, ME 04103-5323 Ph: (401) 649-0753 | Tyler Atkinson, PA-C 13 Industrial Park Rd, Saco, ME 04072-1804 Ph: (207) 283-8800 |
News Archive
Valensa International announced today that it has developed technology that has dramatically increased the stability and shelf-life of the powerful, versatile antioxidant astaxanthin. The company has just completed a 7-year shelf-life study of its Zanthin(R) natural astaxanthin that indicates that this ultra-high pressure supercritical CO2 extract of Haematococcus pluvialis, bolstered by Valensa's proprietary O2B(R) Peroxidation Blocker technology, has a minimum 4-year shelf-life.
The inclusion of biological uncertainty and the latest case data can significantly improve the prediction accuracy of standard epidemiological models of virus transmission, new research led by KAUST and the Kuwait College of Science and Technology (KCST) has shown.
Ocular Therapeutix, Inc. announces the start of its Phase 3 clinical program to evaluate the safety and efficacy of their sustained release dexamethasone, an ophthalmic corticosteroid for the treatment of post-operative inflammation and pain following cataract surgery. Ocular Therapeutix's dexamethasone is administered as a one-time, bioabsorbable intracanalicular plug for release of the steroid to the ocular surface for up 30 days.
Protecting the health of those that consume dietary supplements is of great importance to public health agencies like the Food and Drug Administration (FDA) and the product manufacturers.
› Verified 1 days ago